Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2747.18%
operating margin TTM
-3020.32%
revenue TTM
6.30 Million
revenue per share TTM
0.06$
valuation ratios | |
|---|---|
| pe ratio | -16.24 |
| peg ratio | 0.59 |
| price to book ratio | 6.79 |
| price to sales ratio | 487.20 |
| enterprise value multiple | -18.02 |
| price fair value | 6.79 |
profitability ratios | |
|---|---|
| gross profit margin | 98.89% |
| operating profit margin | -3020.32% |
| pretax profit margin | -2746.18% |
| net profit margin | -2747.18% |
| return on assets | -35.42% |
| return on equity | -43.96% |
| return on capital employed | -41.03% |
liquidity ratios | |
|---|---|
| current ratio | 18.60 |
| quick ratio | 18.56 |
| cash ratio | 1.61 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 5,591.80 |
| operating cycle | 5,706.60 |
| days of payables outstanding | 23,504.18 |
| cash conversion cycle | -17,797.58 |
| receivables turnover | 3.18 |
| payables turnover | 0.02 |
| inventory turnover | 0.07 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.04 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -8.65 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.03 |
| cash per share | 12.40 |
| operating cash flow per share | -3.98 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -8.65 |
| short term coverage ratios | -63.37 |
| capital expenditure coverage ratio | -77.52 |
Frequently Asked Questions
When was the last time Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) reported earnings?
Crinetics Pharmaceuticals, Inc. (CRNX) published its most recent earnings results on 07-05-2026.
What is Crinetics Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)'s trailing twelve months ROE is -43.96%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Crinetics Pharmaceuticals, Inc. (CRNX) currently has a ROA of -35.42%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CRNX's net profit margin stand at?
CRNX reported a profit margin of -2747.18% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CRNX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 18.60 in the most recent quarter. The quick ratio stood at 18.56, with a Debt/Eq ratio of 0.04.